Isolere Bio Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
25
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$62.3M
Isolere Bio General Information
Description
Provider of bioprocessing technology services focuses on simplifying and streamlining the purification of biotherapeutics. The company develops proprietary reagents and accompanying scalable processes that simplify and improve biologic purification workflows while reducing waste, enhancing product quality and accelerating access to life-changing therapies
Contact Information
Website
www.isolerebio.com(Operating Subsidiary)
Corporate Office
- 4021 Stirrup Creek Drive
- Suite 210
- Durham, NC 27703
- United States
Corporate Office
- 4021 Stirrup Creek Drive
- Suite 210
- Durham, NC 27703
- United States
Isolere Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 17-Feb-2023 | $62.3M | Completed | Generating Revenue | ||
| 9. Grant | 01-Feb-2022 | Completed | Generating Revenue | |||
| 8. Grant | 15-Sep-2021 | Completed | Generating Revenue | |||
| 7. Grant | 05-May-2021 | Completed | Generating Revenue | |||
| 6. Seed Round | 31-Mar-2021 | Completed | Generating Revenue | |||
| 5. Grant | 06-Aug-2020 | Completed | Generating Revenue | |||
| 4. Debt - General | 16-Oct-2019 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 2. Grant | 01-Aug-2018 | $722K | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2018 | $224K | Completed | Generating Revenue |
Isolere Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Isolere Bio Comparisons
Industry
Financing
Details
Isolere Bio Competitors (2)
One of Isolere Bio’s 2 competitors is Antibody Research, a Formerly Accelerator/Incubator backed company based in Saint Peters, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Antibody Research | Formerly Accelerator/Incubator backed | Saint Peters, MO | ||||
| BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA |
Isolere Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Isolere Bio Patents
Isolere Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022178537-A1 | Fusion proteins comprising a protein with phase behavior | Inactive | 19-Feb-2021 | ||
| WO-2021168270-A1 | Protein-based purification matrices and methods of using the same | Inactive | 19-Feb-2020 | ||
| WO-2021168276-A1 | Purification matrices comprising aav-binding polypeptides and methods of using the same | Inactive | 19-Feb-2020 | ||
| WO-2020037100-A1 | Genetically encoded polypeptide for affinity capture and purification of biologics | Inactive | 16-Aug-2018 | C07K7/06 |
Isolere Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Isolere Bio Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| North Carolina Biotechnology Center | Not-For-Profit Venture Capital | |||
| Northpond Ventures | Venture Capital | Minority | ||
| U.S. Department of Health and Human Services | Government | |||
| US National Science Foundation | Accelerator/Incubator |
Isolere Bio FAQs
-
When was Isolere Bio founded?
Isolere Bio was founded in 2017.
-
Where is Isolere Bio headquartered?
Isolere Bio is headquartered in Durham, NC.
-
What is the size of Isolere Bio?
Isolere Bio has 25 total employees.
-
What industry is Isolere Bio in?
Isolere Bio’s primary industry is Biotechnology.
-
Is Isolere Bio a private or public company?
Isolere Bio is a Private company.
-
What is the current valuation of Isolere Bio?
The current valuation of Isolere Bio is .
-
What is Isolere Bio’s current revenue?
The current revenue for Isolere Bio is .
-
How much funding has Isolere Bio raised over time?
Isolere Bio has raised $7.25M.
-
Who are Isolere Bio’s investors?
National Institutes of Health, North Carolina Biotechnology Center, Northpond Ventures, U.S. Department of Health and Human Services, and US National Science Foundation have invested in Isolere Bio.
-
Who are Isolere Bio’s competitors?
Antibody Research and BioLegend are competitors of Isolere Bio.
-
When was Isolere Bio acquired?
Isolere Bio was acquired on 17-Feb-2023.
-
Who acquired Isolere Bio?
Isolere Bio was acquired by Donaldson.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
